Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 47,833 | reported | 09 Dec 2025 | tx 283+383,624−478,336 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 4,229 | 701.51 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 3,715 | 0.00 USD | |
| 08 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,699 | 712.94 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 18,315 | 0.00 USD | deriv |
| 29 Oct 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 35,000 | 555.67 USD | |
| 29 Oct 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 32,490 | 648.82 USD | |
| 30 Oct 2025 | GIFT | REGENERON PHARMACEUTICALS, INC. | 1,538 | 0.00 USD | |
| 29 Oct 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 35,000 | 0.00 USD | deriv |
| 16 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,054 | 730.81 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 3,499 | 0.00 USD | |
| 09 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 492 | 787.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 13,472 | 0.00 USD | deriv |
| 08 Nov 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 1,185 | 0.00 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 48 | 1142.94 USD | |
| 13 Aug 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 20,000 | 399.66 USD | |
| 13 Aug 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 13,637 | 1141.49 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 55 | 1140.31 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 331 | 1159.69 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 79 | 1143.28 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 45 | 1144.89 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 148 | 1145.58 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 51 | 1146.60 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 537 | 1148.52 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 294 | 1149.60 USD | |
| 14 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 844 | 1150.41 USD |